What is GHK-Cu?
GHK-Cu stands for glycyl-L-histidyl-L-lysine copper. It is a naturally occurring complex made of three amino acids—glycine, histidine, and lysine—bound to a copper ion. The body naturally produces GHK-Cu, and it has been identified in plasma, saliva, and urine.
A useful way to think about GHK-Cu is as part of the body's repair-signaling system. When tissue is damaged by aging, injury, sun exposure, or training stress, GHK-Cu appears to help coordinate processes involved in collagen production, blood-vessel signaling, tissue remodeling, and cellular repair.
GHK was first isolated from human plasma albumin in 1973 by Loren Pickart after researchers observed that older liver tissue exposed to younger blood behaved more like younger tissue. The active factor associated with that effect was identified as GHK.
Age-Related Decline
Circulating GHK levels decline with age. Commonly cited research estimates suggest plasma levels fall from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60. That decline may contribute to slower tissue repair and reduced skin resilience, although it does not by itself establish that supplementation reverses age-related changes.
In cosmetics, GHK-Cu commonly appears on ingredient labels as Copper Tripeptide-1. Topical cosmetic use has decades of experience behind it. Injectable GHK-Cu, however, is not FDA approved for human use and remains an experimental route with limited human safety data.
GHK-Cu Benefits
GHK-Cu has been studied in laboratory, animal, and human settings. Human evidence is concentrated in topical skin-care applications, while most systemic and injectable findings remain preclinical.
Skin Rejuvenation
Topical trials have reported improvements in skin density, thickness, laxity, fine lines, and wrinkle depth. In one controlled trial using a GHK-Cu nanocarrier serum, wrinkle volume and wrinkle depth improved substantially compared with control serum.
Wound Healing
Animal studies show faster wound closure, granulation tissue formation, epithelialization, collagen deposition, and scar remodeling. These findings support a repair role, but they do not establish an injectable human protocol.
Hair Support
Laboratory research suggests GHK-Cu may support hair-follicle elongation and dermal papilla cell activity. Topical results are generally discussed over a 16- to 24-week timeframe.
Gut Health Research
A 2025 mouse study found improved barrier proteins, reduced inflammatory signaling, and enhanced mucosal healing in experimental colitis through pathways involving SIRT1 and STAT3. Human gut-health evidence is not yet available.
Broader Tissue Repair
Preclinical research has examined GHK-Cu in skin, lung connective tissue, bone, liver, gastrointestinal tissue, ligaments, tendons, and nerves. A rat ACL model showed temporary improvements during treatment.
Antioxidant & Neuroprotective Activity
Cell and animal research suggests protection against oxidative stress and inflammatory damage. Preliminary cognitive findings remain preclinical and have not been established in humans.
Stronger human evidence exists for topical cosmetic use than for injectable or systemic use. Injectable benefit claims remain experimental.
